Bacterial infectious disease
Therapeutic area
Infectious Disease
Rare disease
No
- Definition
- An acute infectious disorder that is caused by gram positive or gram negative bacteria; representative examples include pneumococcal, streptococcal, salmonella, and meningeal infections.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Bacterial infectious disease
- Therapeutic area
- Infectious Disease
- bacterial infectious disease
- Bacteria caused disease or disorder
- Bacteria disease or disorder
- Bacteria infectious disease
- bacterial disease
- bacterial disorder
- bacterial infection
- bacterial infectious disease
- infection, bacterial
- infections, bacterial
- Disease mechanisms
- Acquired
- All therapeutic areas
- Infectious Disease
- Severity
- Severe
- MONDO ID
- MONDO:0005113
- Parent condition
- MONDO:0005550
Related records
Broader conditions (5)
- Disease
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Infectious disease
Narrower conditions (406)
- Abdominal tuberculosis
- Acinetobacter infectious disease
- Actinobacillus infectious disease
- Actinomycetales infectious disease
- Actinomycosis
- Active tuberculosis
- Acute cystitis
- Acute gonococcal cervicitis
- Acute gonococcal cystitis
- Acute gonococcal epididymo-orchitis
- Acute gonococcal prostatitis
- Acute gonococcal salpingitis
- Acute pyelonephritis
- Adult intestinal botulism
- Aerobic Actinomyces infection
- Aeromonas hydrophila infectious disease
- Aeromonas hydrophila intestinal disease
- African tick-bite fever
- Anaerobic bacteria infectious disease
- Anaerobic balanitis
Trials (619)
- : Bacterial Infections in Injecting Drug Users
- [18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
- 0.2% Chx Gel vs Implant Bacterial Contamination
- 11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
- A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)
- A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions
- A Clinical Trial of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)
- A Cluster Randomized Controlled Trial to Compare the Rate of Antibiotic Infusion
- A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the ED With Suspicion of Acute Infection
- A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants
- A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
- A Dried Blood Spot Sampling Method for Vancomycin and Creatinine Monitoring for OPAT
- A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients
- A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers
- A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women
- A First-in-Human Study With XAB05 in Healthy Subjects
- A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
- A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers
- A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated Disease
- A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection
Approved drugs (162)
- Alatrofloxacin mesylate
- Amdinocillin
- Amdinocillin pivoxil
- Amikacin
- Amoxicillin
- Ampicillin
- Azithromycin
- Azlocillin
- Aztreonam
- Bacampicillin
- Bacitracin
- Carbenicillin
- Carbenicillin indanyl
- Cefaclor
- Cefadroxil
- Cefamandole
- Cefazolin
- Cefdinir
- Cefepime
- Cefiderocol
Drugs in development (157)
- Afabicin Phase 2
- Alpibectir Phase 2
- Ancremonam Phase 2
- Apramycin Phase 1
- Arbekacin Phase 2
- Aspoxicillin Phase 2
- Avibactam Phase 3
- Avibactam tomilopil Phase 1
- Azidocillin Phase 2
- Bederocin Phase 1
- Bekanamycin Phase 3
- Biapenem Phase 2
- Brodimoprim Phase 2
- Cadrofloxacin Phase 2
- Calpurbatug Phase 2
- Carumonam Phase 2
- Cefatrizine Phase 2
- Cefazedone Phase 2
- Cefbuperazone Phase 2
- Cefcapene Phase 2
Other linked drugs (47)
- Almecillin
- Benzalkonium chloride
- Candicidin
- Capreomycin
- Carbapenem
- Carbenicillin indanyl sodium
- Cefoselis
- Ceftaroline fosamil acetate
- Ceftiofur
- Ceftolozane
- Cephaloglycin
- Cephalosporin
- Cephalothin sodium
- Cyclacillin
- Cycloserine
- Dalbavancin hydrochloride
- Dalfopristin
- Diaveridine
- Doxorubicin
- Epiroprim